Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. - Wikidata - awgldk - TriplyDB

Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.

Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.

http://www.wikidata.org/entity/Q33664783

about

Microneedle Coating Techniques for Transdermal Drug Delivery Microneedles for intradermal and transdermal drug delivery Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine Universal influenza vaccines, a dream to be realized soon.Microneedle delivery of trivalent influenza vaccine to the skin induces long-term cross-protection.Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice.Formulation of microneedles coated with influenza virus-like particle vaccine.Influenza immunization with trehalose-stabilized virus-like particle vaccine using microneedles Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.Microneedle and mucosal delivery of influenza vaccines.Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.Micro Electromechanical Systems (MEMS) Based Microfluidic Devices for Biomedical Applications.Local transdermal delivery of phenylephrine to the anal sphincter muscle using microneedles.Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization.Stability kinetics of influenza vaccine coated onto microneedles during drying and storage.Dissolving microneedle patch for transdermal delivery of human growth hormone.Vaccine delivery to the oral cavity using coated microneedles induces systemic and mucosal immunity Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles Layer-by-layer assembly of DNA- and protein-containing films on microneedles for drug delivery to the skin Intradermal delivery of vaccines: potential benefits and current challenges.Bacillus Calmette-Guérin vaccination using a microneedle patch.Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin.Enabling skin vaccination using new delivery technologies.Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccination Immunogenicity of low-pH treated whole viral influenza vaccine.Delivery systems for intradermal vaccination Coating solid dispersions on microneedles via a molten dip-coating method: development and in vitro evaluation for transdermal delivery of a water-insoluble drug.Visualization of plasmid delivery to keratinocytes in mouse and human epidermis.Microneedle Vaccination Elicits Superior Protection and Antibody Response over Intranasal Vaccination against Swine-Origin Influenza A (H1N1) in Mice Effect of Osmotic Pressure on the Stability of Whole Inactivated Influenza Vaccine for Coating on Microneedles.Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature A microneedle patch containing measles vaccine is immunogenic in non-human primates.Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin.DNA vaccination in the skin using microneedles improves protection against influenza.Microneedles for drug and vaccine delivery Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch.Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles.Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.

P2860

Q26778139-12EC4341-E60B-45DB-A3DC-0DF63A2C7B0A Q26995148-E1E9519D-8A89-4DF8-B648-88A3C06B8983 Q28728791-D220C9A5-FA54-45CB-9600-E899AE8E5C7E Q30361950-39B7B7C8-0829-44CE-9206-817839CCFEC2 Q30385423-E1DB079A-A61E-4915-8B1C-6E05E2237AE8 Q30391402-14AD176A-29D2-488E-B5D0-13BE355D024B Q30392132-DDE3ADD6-8DB0-4D3A-81D8-B0743545A21C Q30402208-81FFE614-1E18-4368-80F3-8EA9765E737B Q30415387-3A47D6B1-79E4-4E9E-AE6E-1201C6E71105 Q30418015-B60EDA93-0D11-4BA9-B65F-F9304FD539D3 Q30430152-9F812844-FDBB-48AF-AD9B-5D40655EB5B1 Q30474857-1AB4429C-10DF-4E05-B206-127989112A0D Q33829439-4407407C-9515-4662-8096-56C29F066699 Q33964159-A2645873-3F98-4BC8-ACCC-AE309AC97E7D Q34047875-66F26624-3F2A-4B5F-805B-C2502972474E Q34083733-EFE0473B-F67F-4E97-B304-FE8DCC2E56ED Q34175719-4EA1C96D-7461-477E-B541-434BCF6E8B94 Q34288194-138683DE-CCD3-4073-A1FC-D897400ECB57 Q34307510-D0A68004-3BFA-4B64-BA47-93D6F9B585F4 Q34553383-105B82AB-D624-48CF-80DA-174AB89A40A6 Q34601669-3613E634-0B81-4ADB-94C9-616808950975 Q35079453-5652719E-8543-4E6B-B35A-B9B068ECA512 Q35090493-6719DAA3-A4CD-43C5-A649-B4877D27C79E Q35126354-AC1EE79C-E249-49A0-A944-C039DCF039CA Q35129385-82E0C433-F980-478D-ADB6-D1932BE667EF Q35154124-C189ED00-DFCA-4177-B1F2-AB6D8E3AB5B0 Q35214379-D4379C7A-0691-410B-813A-4B33EE9A3A5A Q35219316-F8CB7E53-E2E5-4FE6-83E2-AE7081535F29 Q35619666-8E28F914-C169-4E57-81E4-4B6EC1B690C7 Q35667123-ECCDB493-6FB6-4DC0-99D5-27C4DDBC0201 Q35731299-FECBCE53-8CEE-4F19-AC78-717CE35293BD Q35811003-38D1652C-83EA-443E-9541-0519079E6549 Q35931488-9EEC34DB-8526-4DE1-92FB-F01FE712602D Q36011315-419858B3-07B4-47C6-B5F0-0348DE7C463B Q36020905-6879C726-01F9-4991-A02C-C45F8B021847 Q36085414-7A411D87-163C-485B-BB74-CD25555BBF09 Q36164749-F3BC775F-2BF4-46AF-809E-0B4733CF33C5 Q36175711-D9B61955-7243-4942-A48F-FAB68D4CD668 Q36626140-38861D9C-99E5-449D-AA44-4C372FFF10A6 Q36649709-CFED35F1-9D58-412B-B1C6-AE3B03DE1CF4

P2860

Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.

http://www.wikidata.org/entity/Q33664783

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Formulation and coating of mic ...... stability and immunogenicity.

@ast

Formulation and coating of mic ...... stability and immunogenicity.

@en

type

label

Formulation and coating of mic ...... stability and immunogenicity.

@ast

Formulation and coating of mic ...... stability and immunogenicity.

@en

prefLabel

Formulation and coating of mic ...... stability and immunogenicity.

@ast

Formulation and coating of mic ...... stability and immunogenicity.

@en

P1433

Q33664783-AC706294-E587-44F4-8EA9-EDE21A7BFA49

P1476

Q33664783-84C11A26-15CC-4789-A1A4-8B2D1D0B9946

P2093

Q33664783-AE762471-8E72-4808-9D82-27D4AA57BC55

Q33664783-D282EAC2-23AD-44C2-994B-E5AF5ED336EA

Q33664783-D800F6EA-60D5-477E-AF5B-F4419654DCEC

Q33664783-F06836B9-953E-46FC-B539-B725367307CF

Q33664783-F89EF38B-D619-436C-A40D-B64D7CCD3E08

P2860

Q33664783-0794F6DB-2C4B-475A-B4A2-985FB0E5E263

Q33664783-0B484DBA-9DE7-4984-9F2A-8EB57058DF78

Q33664783-0FD0786F-7904-44F8-8F0F-CC1FC9D44175

Q33664783-1927C6F0-9EA3-4372-9CA8-7224BF25E4D6

Q33664783-1A4E0A0B-A751-49FD-A202-82F36758247B

Q33664783-1F976CA0-BD8C-41E7-BAB2-A958DAA12EEA

Q33664783-22F1D4CE-D134-49D9-ACA7-E649B07E774C

Q33664783-23202C59-463B-46BD-A5EC-19A556BC1382

Q33664783-2F8D3D6A-0637-44A1-92C7-42F0E673EA9E

Q33664783-33C7CD1B-47DA-470D-A95E-AB2200E7E76C

P304

Q33664783-7B9AC0A9-1965-4064-8553-F7BC8D7F4BE5

P31

Q33664783-32014409-2E08-45A9-BFBA-D0E30413EAE7

P356

Q33664783-3434684C-4987-4390-86F1-FB06C94D7A2D

P407

Q33664783-E25E3962-62B9-473F-810E-6527769233ED

P433

Q33664783-DE9FB038-165F-4BF4-9D2C-500171DD28DC

P478

Q33664783-78D01705-75C9-4740-A6A0-18DD0297016F

P577

Q33664783-6787E802-5CA0-479F-83ED-C05AAC3A87D0

P5875

Q33664783-70158560-F9AE-4DEB-AC6E-A056B2A7A633

P698

Q33664783-FED37F74-9B35-4D00-B18C-748F5871879D

P932

Q33664783-573A5909-0D8F-4572-A718-3B6E7A83C5E3

P356

J.JCONREL.2009.10.013

P1433

Journal of Controlled Release

P1476

Formulation and coating of mic ...... stability and immunogenicity.

@en

P2093

Fu-Shi Quan

http://www.w3.org/2001/XMLSchema#string

Mark R Prausnitz

http://www.w3.org/2001/XMLSchema#string

Richard W Compans

http://www.w3.org/2001/XMLSchema#string

Sang-Moo Kang

http://www.w3.org/2001/XMLSchema#string

Yeu-Chun Kim

http://www.w3.org/2001/XMLSchema#string

P2860

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

Low-volume jet injection for intradermal immunization in rabbits

Coated microneedles for transdermal delivery

Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch

Influenza: old and new threats

Influenza-associated hospitalizations in the United States

Role of hemagglutinin cleavage for the pathogenicity of influenza virus.

Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice.

Development of stable influenza vaccine powder formulations: challenges and possibilities

Trehalose and sucrose protect both membranes and proteins in intact bacteria during drying.

P304

187-195

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCONREL.2009.10.013

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

142

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38021878

http://www.w3.org/2001/XMLSchema#string

P698

19840825

http://www.w3.org/2001/XMLSchema#string

P932

2823933

http://www.w3.org/2001/XMLSchema#string